Researchers have tracked how the COVID-19 virus mutates long term, revealing patterns that could help predict the emergence of future variants. In the early days of the COVID-19 pandemic, as the world ...
Patients with systemic autoimmune rheumatic disease demonstrate an increased persistence of SARS-CoV-2 antigen positivity up ...
Researchers at Texas Biomedical Research Institute and the University of Chicago have uncovered a mechanism that SARS-CoV-2, the virus that causes COVID-19, uses to protect itself inside the body as ...
Ensitrelvir represents a significant advancement in the treatment of COVID-19, setting the stage for enhanced defenses ...
India Today on MSN
Ebola vs hantavirus vs SARS Cov2: All you need to know
The World Health Organisation has declared the Ebola outbreak in the DRC and Uganda a global health emergency after the ...
The first known case challenges the notion that the pandemic erupted suddenly. Instead, several peer-reviewed studies ...
Live Science on MSN
A pill can stop people from developing COVID after being exposed to the virus, trial finds
A pill called ensitrelvir is the first drug shown to effectively reduce infection after exposure to SARS-CoV-2.
Scientists in China have found a new coronavirus in bats that could possibly infect humans, but the risk remains low for now. Reading time 3 minutes New research out this month showcases the ...
Kei Sato was looking for his next big challenge five years ago when it smacked him — and the world — in the face. The virologist had recently started an independent group at the University of Tokyo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results